241 related articles for article (PubMed ID: 10969818)
1. p53 promotes selection for Fas-mediated apoptotic resistance.
Maecker HL; Koumenis C; Giaccia AJ
Cancer Res; 2000 Aug; 60(16):4638-44. PubMed ID: 10969818
[TBL] [Abstract][Full Text] [Related]
2. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
[TBL] [Abstract][Full Text] [Related]
3. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
4. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.
Terui T; Murakami K; Takimoto R; Takahashi M; Takada K; Murakami T; Minami S; Matsunaga T; Takayama T; Kato J; Niitsu Y
Cancer Res; 2003 Dec; 63(24):8948-54. PubMed ID: 14695212
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
[TBL] [Abstract][Full Text] [Related]
6. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells.
Tamura T; Aoyama N; Saya H; Haga H; Futami S; Miyamoto M; Koh T; Ariyasu T; Tachi M; Kasuga M
Oncogene; 1995 Nov; 11(10):1939-46. PubMed ID: 7478511
[TBL] [Abstract][Full Text] [Related]
7. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
Naumann U; Kügler S; Wolburg H; Wick W; Rascher G; Schulz JB; Conseiller E; Bähr M; Weller M
Cancer Res; 2001 Aug; 61(15):5833-42. PubMed ID: 11479223
[TBL] [Abstract][Full Text] [Related]
8. CM101 treatment overrides tumor-induced immunoprivilege leading to apoptosis.
Yakes FM; Wamil BD; Sun F; Yan HP; Carter CE; Hellerqvist CG
Cancer Res; 2000 Oct; 60(20):5740-6. PubMed ID: 11059768
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.
Fenton RG; Hixon JA; Wright PW; Brooks AD; Sayers TJ
Cancer Res; 1998 Aug; 58(15):3391-400. PubMed ID: 9699671
[TBL] [Abstract][Full Text] [Related]
10. Role of p53 in regulating constitutive and X-radiation-inducible CD95 expression and function in carcinoma cells.
Sheard MA; Uldrijan S; Vojtesek B
Cancer Res; 2003 Nov; 63(21):7176-84. PubMed ID: 14612511
[TBL] [Abstract][Full Text] [Related]
11. Murine male germ cell apoptosis induced by busulfan treatment correlates with loss of c-kit-expression in a Fas/FasL- and p53-independent manner.
Choi YJ; Ok DW; Kwon DN; Chung JI; Kim HC; Yeo SM; Kim T; Seo HG; Kim JH
FEBS Lett; 2004 Sep; 575(1-3):41-51. PubMed ID: 15388331
[TBL] [Abstract][Full Text] [Related]
12. FK506 restores sensitivity of thymic lymphomas to calcium-mediated apoptosis and the inducible expression of Fas ligand.
Kalas W; Matuszyk J; Ziolo E; Strzadala L
Anticancer Res; 2003; 23(2B):1613-7. PubMed ID: 12820430
[TBL] [Abstract][Full Text] [Related]
13. Farnesyltransferase inhibitors reverse Ras-mediated inhibition of Fas gene expression.
Zhang B; Prendergast GC; Fenton RG
Cancer Res; 2002 Jan; 62(2):450-8. PubMed ID: 11809695
[TBL] [Abstract][Full Text] [Related]
14. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
Ruiz-Ruiz MC; López-Rivas A
Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
[TBL] [Abstract][Full Text] [Related]
15. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.
Burns TF; Bernhard EJ; El-Deiry WS
Oncogene; 2001 Aug; 20(34):4601-12. PubMed ID: 11498783
[TBL] [Abstract][Full Text] [Related]
16. Altered trafficking of Fas and subsequent resistance to Fas-mediated apoptosis occurs by a wild-type p53 independent mechanism in esophageal adenocarcinoma.
Mahidhara RS; Queiroz De Oliveira PE; Kohout J; Beer DG; Lin J; Watkins SC; Robbins PD; Hughes SJ
J Surg Res; 2005 Feb; 123(2):302-11. PubMed ID: 15680394
[TBL] [Abstract][Full Text] [Related]
17. The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma.
Ogawa S; Nagao M; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Nakajima Y
Anticancer Res; 2004; 24(3a):1569-79. PubMed ID: 15274324
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
[TBL] [Abstract][Full Text] [Related]
19. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
[TBL] [Abstract][Full Text] [Related]
20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]